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Microsomal triglyceride transfer protein (MTP) is
needed to assemble chylomicrons in the endoplas-
mic reticulum (ER) of enterocytes. We explored the
role of an ER stress protein, inositol-requiring
enzyme 1b (IRE1b), in regulating this process. High-
cholesterol and high-fat diets decreased intestinal
IRE1b mRNA in wild-type mice. Ire1b/ mice fed
high-cholesterol and high-fat diets developed more
pronounced hyperlipidemia because these mice
secreted more chylomicrons and expressed more
intestinal MTP, though not hepatic MTP, than wild-
type mice did. Chylomicron secretion and MTP
expression also were increased in primary entero-
cytes isolated from cholesterol-fed Ire1b/ mice.
There was no correlation between ER stress and
MTP expression. Instead, cell culture studies re-
vealed that IRE1b, but not its ubiquitous homolog
IRE1a, decreased MTP mRNA through increased
posttranscriptional degradation. Conversely, knock-
down of IRE1b enhanced MTP expression. These
studies show that IRE1b plays a role in regulating
MTP and in chylomicron production.
INTRODUCTION
Chylomicrons are specialized vehicles synthesized by the intes-
tine to transport large quantities of dietary fat and fat-soluble
vitamins (Hussain et al., 1996; Hussain, 2000). Increased absorp-
tion of lipids is associated with metabolic disorders such as obe-
sity, atherosclerosis, and diabetes. Chylomicron biosynthesis
depends on apolipoprotein B (apoB), a structural protein, and
microsomal triglyceride transfer protein (MTP), an endoplasmic
reticulum (ER)-resident chaperone (Hussain et al., 2003a,
2003b). MTP transfers several lipids and helps form primordial
apoB lipoproteins (Hussain et al., 2003a, 2003b). The phospho-
lipid transfer activity ofMTP is sufficient for lipoprotein assembly.
Evolutionarily, it is the oldest activity (Sellers et al., 2003; Rava
et al., 2006; Rava and Hussain, 2007).The central role of the ER in chylomicron assembly prompted
us to examine the inositol-requiring enzyme 1b (IRE1b) in the
intestinal epithelial cells of vertebrates (Bertolotti et al., 2000,
2001; Iwawaki et al., 2001). IRE1b is closely related to the ubiq-
uitously expressed ER stress-response protein IRE1a (Bernales
et al., 2006). IRE1 proteins anchored in the ER membrane con-
tain a sensory domain that is exposed to the lumen and an effec-
tor domain facing the cytosol. The conserved effector domain of
IRE1 is homologous to the viral-induced RNA-degrading enzyme
RNase L. IRE1 proteins mediate the splicing of the X-box-bind-
ing protein 1 (XBP-1) mRNA precursor (Zhang et al., 2005;
Niwa et al., 1999; Calfon et al., 2002). The splicedmRNA is trans-
lated more efficiently, and the synthesized protein acts as a tran-
scription factor for several genes involved in the unfolded protein
response (Yoshida et al., 2001). Although IRE1a acts mainly via
XBP-1 splicing, there are exceptions. Glucose enhances IRE1a
phosphorylation in pancreatic b cells and augments insulin
biosynthesis without increasing XBP-1 splicing (Lipson et al.,
2006). In Drosophila, IRE1 can degrade specific mRNAs under-
going translation at the ER membrane and halt protein synthesis
(Hollien and Weissman, 2006).
Ire1b/ mice develop normally and are fertile, but they are
resistant to toxin-induced colitis (Bertolotti et al., 2001). In this
study, we show that Ire1b/ mice respond to cholesterol-rich
and fat-rich diets with enhanced intestinal MTP expression and
chylomicron production.
RESULTS
Plasma Non-HDL Lipids Are Elevated in Ire1b/ Mice
Fed High-Cholesterol and High-Fat Diets
To test whether IRE1b plays a role in lipid metabolism, Ire1b+/+
(WT) and Ire1b/ (KO) mice were placed on a high-cholesterol
diet or a high-fat western diet for 2 weeks (Figure 1). Compared
with standard chow, a western diet significantly increased
plasma levels of cholesterol and triglyceride in WT mice (Figures
1A and 1B, +/+), similar to the results of other studies (Napoli
et al., 2003). A high-cholesterol diet did not increase plasma
levels of cholesterol and triglyceride in WT SV129 mice (Figures
1A and 1B, +/+), which agrees with the results of Schwarz et al.
(2001). In contrast, because of a 2- to 4-fold increase in non-
high-density lipoprotein (non-HDL) apoB lipoproteins (FiguresCell Metabolism 7, 445–455, May 2008 ª2008 Elsevier Inc. 445
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Regulation of MTP by IRE1bFigure 1. Plasma Non-HDL Lipids Are Elevated and Intestinal Lipids
Are Decreased in Ire1b/ Mice Fed High-Cholesterol and High-Fat
Diets
Wild-type Ire1b+/+ (+/+) and Ire1b/ (/) male mice were fed normal chow,
chow supplemented with 2% w/w cholesterol (average of five experiments
with n = 3–5 animals per group), or a high-fat diet (n = 3 per group) for 2 weeks.
(A–F) Plasma samples were used to measure total, non-HDL, and HDL choles-
terol as well as triglyceride.446 Cell Metabolism 7, 445–455, May 2008 ª2008 Elsevier Inc.1C and 1D), both of these diets significantly increased plasma
levels of cholesterol (Figure 1A) and triglycerides (Figure 1B) in
KO mice. HDL cholesterol and triglyceride levels were similar
in WT and KO mice (Figures 1E and 1F). Gel filtration showed
that lipid levels were increased in all apoB lipoproteins (very
low-density lipoproteins/chylomicrons [VLDL/CM] and low-
density lipoproteins [LDL]) but not in HDL lipids (Figures 1G–
1J) of KO mice. Thus, on high-cholesterol or high-fat diets,
Ire1b/ mice develop more pronounced hyperlipidemia than
WT mice do.
Intestinal Lipid Levels Are Reduced in Ire1b/ Mice
fed High-Cholesterol and High-Fat Diets
WT mice on high-fat and high-cholesterol diets accumulated
significantly higher amounts of cholesterol in their livers com-
pared with chow-fed animals (Figure 1K, +/+), as reported by
Schwarz et al. (2001). Similar increases were seen in KO mice
(Figure 1K,/). There were no significant differences in hepatic
cholesterol and triglyceride levels in cholesterol-fed WT and KO
mice (Figures 1K and 1L, hatched bars). However, hepatic cho-
lesterol and triglyceride levels were higher in KO mice than they
were in WT mice fed a high-fat diet (Figures 1K and 1L, black
bars). KO mice accumulated less intestinal cholesterol and
triglyceride on both diets compared with WT mice (Figures 1M
and 1N). Thus, on high-cholesterol and high-fat diets, Ire1b/
mice show lower intestinal lipid accumulation than WT mice do.
Cholesterol-Fed Ire1b/ Mice Absorb More Lipids
Increases in plasma apoB lipoprotein levels and decreases in
intestinal lipid levels could be explained by similar uptake in
WT and KO mice and enhanced secretion of intestinal lipopro-
teins in KOmice. Long-term cholesterol absorption studies using
a dual-label fecal excretionmethod failed to show any significant
differences (see Figure S1 available online), indicating similar
uptake. Next, we performed short-term absorption studies. Ra-
dioactive cholesterol and triolein (Figures 2A–2D) were fed to
cholesterol-fed WT and KO mice. After 2 hr, there was an
approximately 50% increase in plasma [3H]cholesterol of KO
mice compared with WT mice because of a 3.5-fold increase
in non-HDL apoB lipoproteins, with no change in HDL levels
(Figure 2A). The KO mice also showed an approximately 30%
increase in hepatic [3H]cholesterol (Figure 2B). These studies
show increased absorption of radiolabeled cholesterol by KO
mice. Compared with WT mice, plasma [3H]triolein-derived
counts were approximately 60% higher in KO mice because
of a 2-fold increase in non-HDL apoB lipoproteins (Figure 2C),
but hepatic [3H]triolein counts were similar in these mice
(Figure 2D). These observations are consistent with the under-
standing that absorbed dietary cholesterol and fatty acids are
primarily delivered to the liver and the peripheral tissues, respec-
tively. These results suggest that IRE1b deficiency increases
lipid absorption via apoB lipoproteins.
(G–J) Plasma samples from high-cholesterol (G and H) and high-fat (I and J)
fed animals were separated by gel filtration to measure lipids in different
lipoproteins.
(K–N) Liver and intestinal samples (n = 3) were used tomeasure cholesterol and
triglyceride mass.
Values are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 versus Ire1b+/+.
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Regulation of MTP by IRE1bFigure 2. Intestines from Ire1b/ Mice Secrete More Lipids with Chylomicrons
Ire1b+/+ (+/+; white bars) and Ire1b/ (/; black bars) mice were fed a high-cholesterol diet for 2 weeks and fed 1 mCi of [3H]cholesterol or [3H]triolein as well as
0.1 mg of cholesterol in 15 ml of olive oil.
(A and C) After 2 hr, plasma was used to measure radioactivity.
(B and D) Liver slices were digested with OptiSolv and used for radioactivity determinations.
(E–J) In another experiment, Ire1b+/+ and Ire1b/mice fasted overnight were injected intraperitoneally with poloxamer 407 (30 mg/mouse). After 1 hr, mice were
fed 1 mCi [3H]cholesterol and 0.1 mg unlabeled cholesterol. Plasma was collected after 2 hr and used to measure radioactivity (E) as well as cholesterol (G) and
triglyceride (I) mass in total plasma, HDL, and non-HDL lipoproteins. Plasma was separated by gel filtration to determine lipids in different lipoproteins (F, H,
and J).
(K) Enterocytes were isolated from cholesterol-fed male Ire1b+/+ and Ire1b/ mice and incubated with 1 mCi/ml of [3H]cholesterol for different lengths of time to
study uptake. At each time point, cellular lipids were extracted with isopropanol and counted.
(L) To study secretion, cells were labeled with [3H]cholesterol for 1 hr, washed, and chased for various lengths of time in the presence of 1.2 mM oleic acid.
Radioactivity was measured in conditioned media.
(M and N) To identify lipoproteins carrying cholesterol, enterocytes from cholesterol-fed male Ire1b+/+ and Ire1b/ mice were labeled for 1 hr with 1 mCi/ml of
[3H]cholesterol, washed, and chased for 2 hr in the presence of 1.2 mM oleic acid-containing micelles. Conditioned media were used to measure radioactivity (M)
or for density gradient ultracentrifugation. Fractions were collected from the top and assayed for radioactivity (N).
Each measurement was performed in triplicate with n = 3 mice per group. Values are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 versus Ire1b+/+.To confirm increased lipid absorption in KO mice, mice fed
high-cholesterol diets were injected intraperitoneally with the
lipoprotein lipase inhibitor poloxamer 407 (Millar et al., 2005;
Anwar et al., 2007) and fed 1 hr later with [3H]cholesterol in olive
oil. There was a 90% increase in the appearance of [3H]choles-
terol in the plasma of KO versus WTmice, which was associated
with a 2.2-fold increase in non-HDL (Figure 2E). These counts
were 20 times higher in poloxamer 407-injected animals than
those seen in mice not injected with the lipase inhibitor (compare
to Figure 2A), indicating significant inhibition of lipoprotein clear-ance. Gel filtration analysis showed increased counts in the
apoB lipoproteins (VLDL/CM) of KO mice (Figure 2F). Mass
measurements showed that total plasma cholesterol and triglyc-
eride levels were greater in apoB lipoproteins (Figures 2G–2J).
These studies indicate increased lipid absorption via apoB
lipoprotein production in Ire1b/ mice.
Despite the decreased intestinal cholesterol level in KO mice
(Figures 1M and 1N), isolated primary enterocytes showed
no differences in the uptake of radiolabeled cholesterol
(Figure 2K), and NPC1L1 mRNA levels were similar in WT andCell Metabolism 7, 445–455, May 2008 ª2008 Elsevier Inc. 447
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Regulation of MTP by IRE1bFigure 3. MTP mRNA, Protein, and Activity Are Increased in the Intestines of Ire1b/ Mice
Intestinal and liver samples from Ire1b+/+ (+/+; white bars) and Ire1b/ (/; black bars) mice (n = 3 per group) fed a cholesterol-enriched or fat-enriched diet
were used for MTP activity assays (A, E, I, and M). RNA was used to measure MTP (B, F, J, and N), apoB (C, G, K, and O), GAPDH (D, H, L, and P), and ARPp0
mRNA in triplicate. The ratio between the gene of interest and ARPp0 in Ire1b+/+mice was used to normalize mRNA levels in all samples. Values are mean ± SD.
**p < 0.01, ***p < 0.001 compared to Ire1b+/+. Data are representative of two experiments.KOmice (Figures S2A and S2C). However, cholesterol secretion
was higher in KO enterocytes (Figure 2L). Therefore, KO entero-
cytes take up cholesterol as efficiently as WT enterocytes but
secrete more cholesterol than WT, explaining the lower levels
of intestinal cholesterol in KO mice.
Primary Enterocytes from Cholesterol-Fed Ire1b/
Mice Secrete More Chylomicrons
The gel filtration and lipoprotein precipitation methods used
above (Figures 2A–2J) do not distinguish between different tri-
glyceride-rich lipoproteins. To identify the types of intestinal lipo-
proteins increased in IRE1b deficiency, we studied lipoprotein
production in primary enterocytes isolated from cholesterol-fed
KO and WT mice. [3H]cholesterol secretion was approximately
25% greater in KO enterocytes than it was in WT enterocytes
(Figure 2M), which could reflect a more substantial increase in
chylomicrons with no increase in other lipoproteins. Therefore,
we subjected the conditioned media to potassium bromide den-
sity gradient ultracentrifugation to separate chylomicrons from
other lipoproteins. The WT enterocytes secreted [3H]cholesterol
into chylomicrons at the top of the gradient (Luchoomun and448 Cell Metabolism 7, 445–455, May 2008 ª2008 Elsevier Inc.Hussain, 1999) and into HDL particles at the bottom of the
gradient (Iqbal and Hussain, 2005), consistent with the secretion
of cholesterol via both apoB-dependent and apoB-independent
pathways (Iqbal and Hussain, 2005; Iqbal et al., 2003; Hussain
et al., 2005). The secretion of [3H]cholesterol into chylomicron-
like particles was approximately 3.7-fold greater in KO versus
WT enterocytes (Figure 2N, fraction 1), while secretion into
HDL lipoproteins was similar (Figure 2N, fractions 8–10). Thus,
IRE1b deficiency selectively increases chylomicron secretion.
Intestinal MTP mRNA and Activity Are Elevated
in Cholesterol- and Fat-Fed Ire1b/ Mice
MTP is an essential chaperone and a rate-limiting factor for
chylomicron assembly (Hussain et al., 2003a, 2003b). In fat-fed
animals, the intestines (Figures S3A and S3C), but not the livers
(Figures S3B and S3D), of KO mice had 2- to 3-fold higher
amounts of MTP protein. The triglyceride transfer activity of
MTP was 2- to 2.5-fold higher in KO intestines (Figures 3A and
3I), but hepatic MTP activity was not different (Figures 3E and
3M). Levels of MTP mRNA were 2- to 2.7-fold higher in the intes-
tines of cholesterol-fed and fat-fed Ire1b/ mice (Figures 3B
Cell Metabolism
Regulation of MTP by IRE1band 3J), but there were no differences in apoB (Figures 3C and
3K) or GAPDH (Figures 3D and 3L) mRNA. Hepatic MTP mRNA
levels were similar in KO and WT mice (Figures 3F and 3N), as
were levels of apoB and GAPDH (Figures 3G, 3H, 3O, and 3P).
MTP activity and mRNA levels were not changed in chow-fed
KO or WTmice, and we did not find differences between choles-
terol-fed KO and WT animals in the intestinal and hepatic mRNA
levels of several ER proteins involved in lipid metabolism and ER
stress responses (Figures S2A–S2D). Thus, IRE1b deficiency in
cholesterol-fed and fat-fed mice leads to a selective increase
in intestinal MTP.
To test whether increases in MTP lead to increased apoB
lipoprotein secretion, we transfected COS cells, which do not
Figure 4. XBP-1 Splicing Does Not Regulate
MTP
RNA was isolated from the intestinal tissues of
Ire1b+/+ and Ire1b/ mice (n = 3) fed with or with-
out high-cholesterol or high-fat diet for 2 weeks.
(A) Spliced and unspliced XBP-1 mRNA levels.
(B–D, G, and H) Intestinal RNA was used to deter-
mine in triplicate the levels of IRE1a (B), BiP (C),
CHOP (D), MTP (G), and IRE1b (H) mRNAs. Values
are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001
versus chow-fed animals.
(E and F) RNA also was isolated from the primary
enterocytes of Ire1b+/+ and Ire1b/ mice fed a
high-cholesterol diet and used to quantify mRNA
levels of ER stress and lipoprotein genes (E) and
XBP-1 splicing (F). RNA from Huh7 cells treated
with tunicamycin (5 mg/ml) was used as a control
(F). Values are mean ± SD. ***p < 0.001 versus
Ire1b+/+.
(I and K) Differentiated Caco-2 cells were treated
with tunicamycin (5 mg/ml) or thapsigargin (1 mM)
for 17 hr and used to quantify spliced as well as
unspliced XBP-1 mRNA (I) and to measure MTP,
IRE1a, BiP, CHOP, and ARPp0 mRNA (K).
(J and L) Enterocytes isolated from Ire1b+/+ mice
were treated with tunicamycin (10 mg/ml) or thapsi-
gargin (5 mM) for 3 hr and used to measure XBP-1
splicing (J) and MTP, IRE1a, BiP, CHOP, and
ARPp0 mRNA (L).
express apoB or MTP, with an apoB48
expressionplasmidanddifferent amounts
of a human MTP-FLAG expression plas-
mid (Figure S4). No apoB was secreted
in the absence of MTP, but apoB secre-
tion increased as MTP expression in-
creased, consistent with other studies
(Gordon et al., 1994; Leiper et al., 1994).
Changes in MTP Expression
Are Not Correlated with ER Stress
We next sought to identify how IRE1b
deficiency leads to increased MTP.
Although IRE1b-mediated XBP-1 mRNA
splicing in cholesterol-fed WT mice could
theoretically suppress MTP mRNA, intes-
tinal samples from chow-fed and cholesterol-fed animals did not
induce XBP-1 mRNA splicing (Figure 4A) or IRE1a, BiP, or CHOP
mRNA levels, which increase during ER stress (Figures 4B–4D).
To increase sensitivity, we used enterocytes isolated from cho-
lesterol-fed WT and KO mice and found an increase in MTP
mRNA levels but no changes in IRE1a, BiP, or CHOP
(Figure 4E) or in XBP-1 mRNA splicing (Figure 4F). As a control,
XBP-1 mRNA splicing was evident in tunicamycin-exposed hu-
man hepatoma Huh7 cells (Figure 4F). These data indicate that
a high-cholesterol diet does not induce intestinal ER stress. In
contrast, the high-fat diet induced similar levels of ER stress in
the intestines of both WT and KO mice, as evidenced by XBP-1
mRNA splicing (Figure 4A), and increases in IRE1a, BiP, andCell Metabolism 7, 445–455, May 2008 ª2008 Elsevier Inc. 449
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Regulation of MTP by IRE1bCHOPmRNA (Figures 4B–4D). Thus, induction of ER stress is in-
dependent of genotype and is a consequence of a high-fat diet.
In WT mice, a high-fat diet increased intestinal MTP mRNA by
68% (Figure 4G, +/+). High-cholesterol diet and high-fat diet
increased intestinal MTP mRNA in KO mice 2-fold and 3-fold
(Figure 4G, /), respectively, compared with chow-fed WT.
The high-cholesterol and high-fat diets decreased IRE1b mRNA
levels by 33% and 59%, respectively, in WT mice (Figure 4H,
+/+). Thus, both diets reduce intestinal IRE1b in WT mice but in-
creaseMTPmRNA in Ire1b/mice. Direct cell stress and activa-
tion of XBP-1 splicing in Caco-2 human colon carcinoma cells
(Figure 4I) and primary enterocytes (Figure 4J) by tunicamycin
or thapsigargin did not affect MTP mRNA (Figures 4K and 4L) or
activity (data not shown) but did increase IRE1a, BiP, and
CHOP mRNA levels.
Figure 5. Overexpression of IRE1b
Decreases MTP mRNA Levels
(A) Huh7 cells transfected with different c-Myc-
tagged IRE1b expression plasmids were used to
determine protein expression using c-Myc anti-
bodies.
(B) Total RNA from IRE1b-DC- and IRE1b-WT-
transfected Huh7 cells was loaded on 1% agarose
gels to visualize changes in 18S and 28S rRNA.
(C–E) Cells from three wells were used to measure
MTP (C) and PDI (E) mRNA in triplicate. Media
were used to measure apoB secretion (D).
*p < 0.05, **p < 0.01 compared to pcDNA3.1-
treated cells.
(F) RNA interference was used to knock down
IRE1b in undifferentiated Caco-2 cells. siGL2
served as a control. Cells were treated with siRNA
targeting IRE1b and used to measure IRE1b, MTP,
IRE1a, and PDI mRNAs. ***p < 0.001 compared to
siGL2-treated cells.
(G andH) To study the effect of cholesterol onMTP
expression, Huh7 cells were transfected with
either IRE1b-WT or IRE1b-DC expression plas-
mids. After 12 hr, cells were supplemented with
or without cholesterol (40 mg/ml), and MTP and
ARPp0 mRNA were quantitated (G). Cells treated
in parallel were used for MTP activity assays (H).
**p < 0.01, ***p < 0.001 compared to IRE1b-DC-
overexpressing cells without cholesterol treat-
ment.
(I and J) Huh7 cells were transfected with IRE1b
expression plasmids or treated with 5 mg/ml tuni-
camycin. Total RNA was isolated and used to
measure MTP, IRE1a, BiP, and CHOP mRNA (I).
***p < 0.001 compared to IRE1b-DC-overexpress-
ing cells. In addition, RNA was used to determine
XBP-1 splicing (J).
Data are representative of two experiments
performed in triplicate. Values are mean ± SD.
In summary, a high-cholesterol diet
does not induce ER stress but increases
intestinal MTP mRNA in KO mice. A
high-fat diet induces similar ER stress in
both WT and KO mice but significantly
induces MTP mRNA only in the intestines
of KO mice. Furthermore, induction of
ER stress and XBP-1 in intestinal cells does not affect MTP
expression.
MTPmRNAChanges Proportionally to IRE1bExpression
To test whether MTP is directly suppressed by IRE1b, we trans-
fected human hepatoma Huh7 cells, which express MTP but not
IRE1b, with c-Myc-tagged plasmids expressing full-length IRE1b
(IRE1b-WT) and C-terminally truncated IRE1b (IRE1b-DC) lack-
ing the kinase and endoribonuclease domains (Figure 5A) (Urano
et al., 2000; Wang et al., 1998). Expression of IRE1b-DC did not
affect MTP mRNA (Figure 5C), apoB secretion (Figure 5D), or
protein disulfide isomerase (PDI) mRNA (Figure 5E). IRE1b-WT
expression reduced 28S rRNA (Figure 5B) consistent with
Iwawaki et al. (2001), suppressed MTP mRNA (Figure 5C), and
decreased apoB lipoprotein secretion (Figure 5D) but did not450 Cell Metabolism 7, 445–455, May 2008 ª2008 Elsevier Inc.
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Regulation of MTP by IRE1baffect PDI (Figure 5E) or apoB, apoAI, ACAT1, ACAT2, MGAT2,
MGAT3, DGAT1, DGAT2, or NPC1L1 mRNA (Figure S2E),
suggesting no general effects on cell health.
We next determined the consequences of decreasing IRE1b
on MTP expression in undifferentiated Caco-2 cells through
RNA interference. IRE1b siRNA reduced its target mRNA
by 60% with no effect on IRE1a mRNA (Figure 5F). More impor-
tantly, IRE1b knockdown increased MTP mRNA by 50%
(Figure 5F) and did not affect PDI mRNA. These data show that
expression and suppression of IRE1b lead to specific changes
in MTP mRNA through a mechanism that requires the kinase
and ribonuclease domains.
To investigate why cholesterol feeding was necessary to
observe differences in plasma lipid levels in WT and KO mice,
Huh7 cells were transfected with IRE1b-WT or IRE1b-DC and
cultured in the presence or absence of cholesterol. Cholesterol
treatment of cells expressing IRE1b-DC significantly increased
MTP mRNA (Figure 5G) and activity (Figure 5H), as occurred in
KO mice fed a high-cholesterol diet (Figures 3A and 3B). In con-
trast, cholesterol supplementation of cells expressing IRE1b-WT
did not affect MTP mRNA (Figure 5G) or activity (Figure 5H).
Therefore, IRE1b counteracts cholesterol-induced increases in
MTP expression. Similar studies were not performed with high
fatty acid concentrations because they are toxic to cells.
Next, we askedwhether overexpression of IRE1b in Huh7 cells
increases ER stress and decreases MTP mRNA. Expression of
IRE1b-DC and IRE1b-WT had no effect on IRE1a, BiP, or
CHOP mRNA (Figure 5I), and no splicing of XBP-1 occurred in
these cells (Figure 5J). On the other hand, treatment of Huh7
cells with tunicamycin increased ER stress indicators, IRE1a,
BiP, CHOP, and XBP-1 splicing (Figures 5I and 5J). Thus,
Huh7 cells respond to ER stress transducers but do not upregu-
late these genes when transfected with IRE1b. We conclude that
IRE1b decreases MTP levels without inducing an ER stress
response.
IRE1b Decreases MTP mRNA by Promoting
Posttranscriptional Degradation
To determine whether IRE1b-mediated suppression of MTP
mRNA occurs at the transcriptional level, we determined the
promoter activity of a 1.5 kb sequence upstream of the transcrip-
tion initiation site. Luciferase activity expressed under the control
of the MTP (mttp) promoter could be measured in Huh7 and
Caco-2 cells but not HEK293 cells (Figure 6A), indicating that
the promoter is sufficient for expression in the intestine and liver;
this is consistent with other studies showing that 204 bases are
sufficient for MTP expression (Hagan et al., 1994; Hirokane et al.,
2004; Kang et al., 2003). To evaluate whether IRE1b affectsmttp
promoter activity, we cotransfected Huh7 cells with a plasmid
expressing luciferase under the control of the 1.5 kb mttp
promoter as well as pcDNA3.1, IRE1b-WT, or IRE1b-DC expres-
sion plasmids. IRE1b-WT did not suppress mttp promoter
activity compared with vector control or IRE1b-DC (Figure 6B),
indicating that IRE1b does not reduce MTP levels by altering
mttp promoter activity.
To explore posttranscriptional mechanisms, we used mouse
fibroblast L cells stably transfected with mouse MTP cDNA
under the control of the cytomegalovirus promoter (Dougan
et al., 2007). Expression of IRE1b-WT in these cells reducedendogenous MTP mRNA (Figure 6C), activity (Figure 6D), and
protein (Figure 6D inset). In contrast, IRE1b-DC and IRE1a had
no effect on MTP mRNA (Figure 6C), activity (Figure 6D), or pro-
tein (Figure 6D inset). To explore whether IRE1b decreases the
stability of MTP mRNA, Huh7 cells expressing IRE1b-WT or
IRE1b-DC were treated with actinomycin D to block new
mRNA transcription. MTP mRNA, but not PDI mRNA, decayed
at a greater rate in cells expressing IRE1b-WT than in cells
expressing IRE1b-DC (Figure 6E), indicating that IRE1b-WT
promotes MTP mRNA degradation.
A plausible scenario for MTP mRNA degradation would
involve its cleavage by IRE1b endonuclease activity (Fig-
ure 6F), followed by exonuclease digestion of the cleaved pro-
ducts. In this context, the exonucleases Ski2 and XRN1/2 may
perform 30/50 and 50/30 exonuclease digestion, respectively,
of endonuclease-cleaved mRNA (Newbury, 2006; Houseley
et al., 2006; Meyer et al., 2004). Thus, knockdown of these
exonucleases should preserve the putative 50 or 30 cleavage
products of MTP mRNA. To test this, Huh7 cells were trans-
fected with IRE1b-WT or IRE1b-DC and treated with Ski2,
XRN1, XRN2, or control GL2 siRNA, which specifically reduced
70%–75% of the target mRNAs (Figure 6G). Expression of
IRE1b-WT decreased MTP mRNA sequences corresponding to
exons 1–2 (50) and exons 7–8 (30) when treated with control
GL2 siRNA but did not affect PDI mRNA levels (Figure 6H,
WT+GL2). Treatment with Ski2 siRNA prevented the loss of
sequences corresponding to MTP exons 1–2 but not exons
7–8 (Figure 6H, WT+Ski2). Similarly, XRN1 and XRN2 siRNA
selectively limited the loss of exons 7–8. These data are consis-
tent with IRE1b-dependent endonuclease cleavage between
exons 2 and 7, followed by 30/50 exonuclease cleavage of the
50 fragment(s) by Ski2 and 50/30 exonuclease cleavage of the
30 fragment(s) by XRN1 and XRN2.
DISCUSSION
IRE1b deficiency in mice enhances intestinal MTP expression
without affecting hepatic MTP and increases lipid absorption
and chylomicron secretion in response to high-cholesterol and
high-fat diets. IRE1b reduces MTP mRNA levels by augmenting
posttranscriptional degradation. Thus, the present study iden-
tifies an intestine-specific mechanism controlling the assembly
and secretion of apoB lipoproteins, wherein IRE1b regulates
chylomicron production by degrading MTP mRNA.
Eating high-cholesterol and high-fat diets enhances MTP
expression in the liver, and to a lesser extent in the intestine, of
WT mice. In contrast, diet-induced increases in intestinal and
hepatic MTP are similar in KOmice. These observations indicate
thatMTP expression ismore responsive to dietary manipulations
in the absence of IRE1b and that IRE1b blocks diet-induced
upregulation of intestinal MTP in WT mice.
Ire1b/ mice fed high-cholesterol or high-fat diets produce
more intestinal apoB lipoproteins both in vivo (Figures 2A–2J)
and in isolated enterocytes (Figures 2M and 2N), which elimi-
nates generalized intestinal damage, permeability, and other
pathological mechanisms as potential explanations for this
increase. This increased apoB lipoprotein production is probably
secondary to increased MTP activity because (1) IRE1b defi-
ciency did not affect apoB mRNA, (2) changes in MTPCell Metabolism 7, 445–455, May 2008 ª2008 Elsevier Inc. 451
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Regulation of MTP by IRE1bFigure 6. IRE1b Enhances Posttranscriptional Degradation of MTP mRNA
(A) Caco-2, Huh7, and HEK293 cells in 12-well plates were cotransfectedwith 40 ng of control plasmid (pCMV-RL) and 1 mg of pGL2 plasmid DNAswith luciferase
under the control of various lengths (204 to 1483 bp) of 50 sequences upstream of the humanMTTP gene. Cells were collected 48 hr later and analyzed with
a Dual-Luciferase Reporter kit (Promega).
(B) Promoter activity assays were performed using the dual-luciferase assay system. pCMV-Renilla luciferase served as a control for transfection efficiency. Huh7
cells were transfected with 20 ng pCMV-Renilla luciferase and 1 mg pMTP-1483-luciferase (expressing luciferase activity under the control of a 1.5 kbMTTP pro-
moter) with pcDNA3.1, IRE1b-DC (100 ng), or IRE1b-WT (100 ng). After 48 hr, luciferase activity was measured.
(C and D) Mouse fibroblasts L cells stably expressing mouse MTP under the control of the cytomegalovirus promoter were transfected with different plasmids.
After 48 hr, MTP mRNA (C) and activity (D) were measured in triplicate. Inset in (D) shows western blot of a representative sample. *p < 0.05, **p < 0.01 versus
pcDNA3.1-treated cells.
(E) Huh7 cells were transfected in triplicate with either IRE1b-WT or IRE1b-DC expression plasmid DNA. After overnight incubation, cells were cultured in the
presence of actinomycin D (1 mg/ml) for different lengths of time in triplicate. RNA was used to quantify MTP, PDI, and ARPp0 mRNA. The MTP/ARPp0 or
PDI/ARPp0 ratio at time 0 was normalized to 100%, and loss of MTP was plotted versus time.
(F) Schematic representation of possible internal cleavage of MTP mRNA by IRE1b and its subsequent degradation by different exonucleases.
(G) Huh7 cells were transfected with IRE1b-WT. After 24 hr, cells were transfected with siRNAs against Ski2, XRN1, or XRN2. RNA was isolated after 48 hr and
used to quantify Ski2, XRN1, or XRN2 mRNA in control (siGL2) and RNAi-treated cells to determine the efficacy and specificity of RNA interference.
(H) Huh7 cells were transfected in triplicate with IRE1b-DCor IRE1b-WT expression plasmids. After 24 hr, cells were transfectedwith indicated siRNAs. Total RNA
from these cells was used to amplify different regions (exons 1–2 and exons 7–8) of MTP mRNA using primers listed in Table S1.
Data are representative of two experiments performed in triplicate. Values are mean ± SD.452 Cell Metabolism 7, 445–455, May 2008 ª2008 Elsevier Inc.
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Regulation of MTP by IRE1bexpression significantly altered the secretion of apoB lipopro-
teins (Figure S4), and (3) changes in MTP levels affect plasma
lipid and apoB lipoprotein levels (Tietge et al., 1999; Ameen
et al., 2005; Wolfrum and Stoffel, 2006; Lin et al., 1994). Con-
versely, repression of MTP was associated with decreased
apoB secretion. Chenodeoxycholate reduces MTP expression
and apoB secretion in HepG2 cells (Hirokane et al., 2004).
MTP antagonists reduce plasma lipids (Cuchel et al., 2007; Wet-
terau et al., 1998). Thus, changes in MTP activity significantly af-
fect plasma apoB lipoprotein levels. Therefore, increases in MTP
due to IRE1b deficiency are sufficient to augment apoB lipopro-
tein production.
mttp/ mice are not viable (Raabe et al., 1998). Chow-fed
heterozygous mttp+/ mice have plasma lipid levels similar to
WT mice but significantly lower intermediate-density lipoprotein
(IDL)/LDL cholesterol. A high-fat diet significantly lowers plasma
cholesterol inmttp+/mice owing to a marked reduction in VLDL
and LDL cholesterol, and hepatocytes isolated from mttp+/
mice secrete less apoB lipoprotein (Raabe et al., 1998). Half-
normal MTP levels reduce apoB lipoprotein secretion to a similar
extent in apob+/ and apoB transgenic mice (Leung et al., 2000).
Therefore, MTP deficiency reduces apoB lipoprotein production
and decreases plasma cholesterol when challenged with a high-
fat diet. In Ire1b/ mice, increases in intestinal MTP increase
apoB lipoprotein production and enhance plasma cholesterol
levels.
In abetalipoproteinemia, MTP deficiency significantly reduces
total and LDL cholesterol. In general, obligate MTTP heterozy-
gotes present with normal plasma cholesterol, but several
parents of abetalipoproteinemia patients have been found to
have low cholesterol (Raabe et al., 1998; Narcisi et al., 1995; Ber-
riot-Varoqueaux et al., 2000; Di Leo et al., 2005). The variations in
plasma cholesterol in heterozygotes might result from an adap-
tation involving increased synthesis of MTP by the normal allele
(Berriot-Varoqueaux et al., 2000). Moreover, plasma apoB lipo-
proteins have not been characterized, and high-fat feeding stud-
ies have not been performed in heterozygotes. Therefore, there
are insufficient data to draw conclusions about the effect of
half-normal MTP levels on plasma apoB lipoproteins.
Although IRE1 functions primarily via splicing XBP-1 mRNA, it
represses ER-targeted mRNA independently of the XBP-1 path-
way (Hollien and Weissman, 2006). IRE1b may reduce protein
synthesis by cleaving 28S ribosomal RNA (Iwawaki et al.,
2001). IRE1a regulates proinsulin synthesis without enhancing
XBP-1 splicing (Lipson et al., 2006). We did not observe spliced
XBP-1 mRNA in the intestines of cholesterol-fed WT mice, and
induction of XBP-1 splicing by tunicamycin and thapsigargin
did not alter MTP mRNA levels (Figure 4). Thus, intestinal
IRE1b regulates MTP independently of the XBP-1 pathway.
Despite the sequence homology between IRE1a and IRE1b,
the effect on MTP mRNA regulation was specific to IRE1b
(Figure 6C). The cytosolic domains that contain the kinase and
endoribonuclease activities in mouse IRE1b and IRE1a exhibit
62%–63% identity, but the identity of the luminal domains is
only 41%. Therefore, IRE1b may have evolved to detect a
specific luminal signal—for example, fat status.
The posttranscriptional degradation of MTP mRNA could in-
volve direct endolytic cleavage. IRE1b and MTP mRNA transla-
tion are associated with the ER membrane, and overexpressionofMTPmay therefore facilitate its degradation by IRE1b. Alterna-
tively, increased chylomicron assembly may temporarily stall the
protein translational machinery, leading to the recognition of the
MTPmRNA by IRE1b directly or via recruitment/activation of an-
other endonuclease. If so, all components are present in the liver,
and IRE1b may be the limiting factor for MTP downregulation.
We can only speculate as to why the enterocytes of
vertebrates have this regulatory pathway to control chylomicron
assembly. One hypothesis is that enterocytes optimize fat
absorption by activating the ER stress response and downregu-
lating IRE1b. By upregulating the ER stress response, the ER
is protected from the increased load of synthesizing and pack-
aging chylomicrons. By downregulating IRE1b, chylomicron
assembly is maximized by enhancing MTP. In the fasting state,
it may be beneficial to limit chylomicron secretion by degrading
MTP mRNA to conserve critical cellular lipids and fat-soluble
vitamins and to avoid rapid fluctuations in membrane phospho-
lipids, neutral lipids, and vitamin E. Alternatively, IRE1b may
mediate downregulation of chylomicron secretion in response
to satiety signals or respond to endocrine factors from the liver
and adipose tissue under conditions of excess whole-body lipid
accumulation. In the absence of IRE1b, this postprandial mech-
anism of optimizing fat absorption is derailed, leading to a
sustained hyperlipidemia.
In summary, these studies highlight an intestine-specific
mechanism controlling lipid absorption. In this mechanism,
IRE1b regulates MTP mRNA levels involving posttranscriptional
degradation. IRE1b restricts MTP induction in the intestine by
high-fat and high-cholesterol diets. These findings raise the
possibility that upregulation of IRE1bmay be beneficial in avoid-
ing diet-induced hyperlipidemia.
EXPERIMENTAL PROCEDURES
Materials
[1,2-3H]cholesterol and [3H]triolein were from NEN Life Science Products.
Oleic acid, cholate, deoxycholate, taurocholate, and monoacylglycerol were
from Sigma. Phosphatidylcholine was from Avanti Polar Lipids. Other
chemicals and solvents were from Fisher Scientific.
Animals and Diets
Ire1b/ (KO) and Ire1b+/+ (WT) mice on an SV129 background were used
(Bertolotti et al., 2001). To study the effects of a high-cholesterol diet, 10- to
16-week-old male mice were fed a chow diet containing 2% w/w cholesterol
for 14 days, with no significant effect on body weight. Histologic analyses
revealed no overt differences in epithelial cell morphology or crypt cell mitotic
figures. To study the effects of a high-fat diet, male WT and KO mice were fed
a high-fat western diet containing 17%, 48.5%, 21.2%, and 0.2% by weight of
protein, carbohydrate, fat, and cholesterol, respectively (TD88137, Harlan
Teklad). Food was withdrawn the night before the experiments.
Plasma Lipid Measurements
Total cholesterol and triglyceride levels were measured using kits (Thermo
Trace Ltd.). HDL lipid levels were measured after precipitating apoB lipopro-
teins (Iqbal and Hussain, 2005). Lipid levels in apoB lipoproteins were deter-
mined by subtracting HDL lipid levels from total lipid levels. Plasma lipopro-
teins were separated by gel filtration (flow rate of 0.2 ml/min) using
a Superose 6 column, and 200 ml fractions were collected.
Short-Term Lipid Absorption Studies
Age-matched male mice (n = 3 per group) fed a high-cholesterol diet for
2 weeks were fasted overnight and gavaged with 1 mCi of either [3H]triolein
or [3H]cholesterol and 0.1 mg of unlabeled cholesterol in 15 ml of olive oil (IqbalCell Metabolism 7, 445–455, May 2008 ª2008 Elsevier Inc. 453
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Tissues (0.1 g) were rinsed and dissolved in 1 ml OptiSolv, and radioactivity
was counted.
Secretion of [3H]Cholesterol by Primary Enterocytes
Primary enterocytes from WT and KO mice (Iqbal et al., 2003; Iqbal and
Hussain, 2005) were suspended in 4 ml of DMEM containing 1 mCi/ml of
[3H]cholesterol and incubated at 37C. Enterocytes were incubated for 1 hr
with micelles containing 1.2 mM oleic acid (Iqbal et al., 2003; Iqbal and Hus-
sain, 2005). After 2 hr, enterocytes were centrifuged and supernatants were
subjected to density gradient ultracentrifugation. Fractions were collected
and radioactivity was counted. Cell pellets were incubated overnight at 4C
with 1ml isopropanol to extract lipids. After extraction, proteinswere dissolved
in 1 ml of 0.1 N NaOH and quantified using Coomassie reagent (Pierce Chem-
ical Company).
Determination of MTP Activity
Small pieces (0.1 g) of liver and proximal small intestine (1 cm) were homog-
enized in low-salt buffer and centrifuged, and supernatants were used for
protein determination and MTP assay (Athar et al., 2004; Rava et al., 2005)
using a kit (Chylos Inc.).
RNA Isolation and Two-Step Quantitative RT-PCR
Total RNA from tissues and cells was isolated using TRIzol (Invitrogen). Purity
and integrity were assessed by the A260/A280 ratio and 1% agarose gel electro-
phoresis, respectively. RNAs with ratios greater than 1.7 were used for cDNA
synthesis. The first-strand cDNA was synthesized with an Omniscript RT kit
(QIAGEN) and used for quantitative RT-PCR (qPCR Core Kit for SYBRGreen I,
Eurogentec). Data were analyzed using the DDCT method and are presented
as arbitrary units. The primers used were designed using PrimerExpress 3.0
(Applied Biosystems) and are listed in Table S1. A two-step RT-PCR method
was used to determine XBP-1 RNA splicing. The primers (Table S1) were
designed to differentiate the two forms of XBP-1, which differ by 26 nucleo-
tides. The PCR products were separated by 3% agarose or 12% polyacryl-
amide gels.
Plasmid Expression
The expression plasmids pIRE1b-WT and pIRE1b-DC have been described
previously (Urano et al., 2000). Plasmid pMTP1483 was generated by cloning
a 1.4 kbmttp promoter into a pGL2 basic vector. Huh7 cells with endogenous
MTP and mouse fibroblast L cells expressing mouse MTP under the control of
the cytomegalovirus promoter (Dougan et al., 2007) were plated in 100 mm
dishes. ExGen 500 (Fermentas) and PolyFect (QIAGEN) were used to transfect
cells. After 24–48 hr transfection, cells were used to measure MTP protein and
activity (Athar et al., 2004; Rava et al., 2005) as well for RNA extraction.
Small RNA Interference
Huh7 cells transfected with IRE1b-WT or IRE1b–DC plasmids for 8 hr were
transfected with siRNA against the exoribonucleases Ski2, XRN1, and XRN2
or control siGL2 by the siPORT NeoFX agent (Ambion). After 48 hr, RNA was
extracted and used for quantitative RT-PCR.
Western Blot Analyses
Tissue and cell samples were homogenized in PBS containing 1% Triton
X-100. Proteins (40 mg) were resolved on 4%–20% gradient gels (Bio-Rad).
A monoclonal MTP antibody (BD Biosciences), rabbit anti-PDI (Santa Cruz),
and mouse anti-GAPDH (Santa Cruz) were used to detect endogenous
proteins. Overexpressed tagged mouse IRE1b proteins were detected using
anti-c-Myc (9E10, Santa Cruz) antibodies. Secreted apoB was immunoprecip-
itated with goat anti-human apoB100 antibody and immunoblotted with 1D1
monoclonal antibody (Academy Bio-Medical Company, Inc.). MTP-FLAG
was detected using anti-FLAG (Sigma) antibody. The resulting blots were
developed using an ECL kit (Amersham). To quantify mass, in some western
blots, we used Alexa Fluor 633 (Invitrogen) anti-mouse or anti-rabbit second-
ary antibodies and evaluated the blots using Storm 860 (Amersham). Bands
were quantified using Scion Image (Scion Corporation).454 Cell Metabolism 7, 445–455, May 2008 ª2008 Elsevier Inc.Statistics
Data are presented as mean ± SD. Unless noted otherwise, n = 3 for each
group or condition. Statistical significance (p < 0.05) was determined using
Student’s t test (GraphPad Prism).
SUPPLEMENTAL DATA
Supplemental Data include four figures, one table, and Supplemental
References and can be found with this article online at http://www.
cellmetabolism.org/cgi/content/full/7/5/445/DC1/.
ACKNOWLEDGMENTS
This work was supported in part by NIH grants HL64272 (M.M.H.), HL75662
(I.T.), and DK47119 (D.R.).
Received: September 17, 2007
Revised: December 30, 2007
Accepted: March 10, 2008
Published: May 6, 2008
REFERENCES
Ameen, C., Edvardsson, U., Ljungberg, A., Asp, L., Akerblad, P., Tuneld, A.,
Olofsson, S.O., Linden, D., and Oscarsson, J. (2005). Activation of peroxisome
proliferator-activated receptor alpha increases the expression and activity of
microsomal triglyceride transfer protein in the liver. J. Biol. Chem. 280,
1224–1229.
Anwar, K., Iqbal, J., and Hussain, M.M. (2007). Mechanisms involved in vitamin
E transport by primary enterocytes and in vivo absorption. J. Lipid Res. 48,
2028–2038.
Athar, H., Iqbal, J., Jiang, X.C., and Hussain, M.M. (2004). A simple, rapid, and
sensitive fluorescence assay for microsomal triglyceride transfer protein.
J. Lipid Res. 45, 764–772.
Bernales, S., Papa, F.R., and Walter, P. (2006). Intracellular signaling by the
unfolded protein response. Annu. Rev. Cell Dev. Biol. 22, 487–508.
Berriot-Varoqueaux, N., Aggerbeck, L.P., Samson-Bouma, M., and Wetterau,
J.R. (2000). The role of the microsomal triglyceride transfer protein in abetali-
poproteinemia. Annu. Rev. Nutr. 20, 663–697.
Bertolotti, A., Zhang, Y., Hendershot, L.M., Harding, H.P., and Ron, D. (2000).
Dynamic interaction of BiP and ER stress transducers in the unfolded-protein
response. Nat. Cell Biol. 2, 326–332.
Bertolotti, A., Wang, X., Novoa, I., Jungreis, R., Schlessinger, K., Cho, J.H.,
West, A.B., and Ron, D. (2001). Increased sensitivity to dextran sodium sulfate
colitis in IRE1beta-deficient mice. J. Clin. Invest. 107, 585–593.
Calfon, M., Zeng, H., Urano, F., Till, J.H., Hubbard, S.R., Harding, H.P., Clark,
S.G., and Ron, D. (2002). IRE1 couples endoplasmic reticulum load to
secretory capacity by processing the XBP-1 mRNA. Nature 415, 92–96.
Cuchel, M., Bloedon, L.T., Szapary, P.O., Kolansky, D.M., Wolfe, M.L., Sarkis,
A., Millar, J.S., Ikewaki, K., Siegelman, E.S., Gregg, R.E., and Rader, D.J.
(2007). Inhibition of microsomal triglyceride transfer protein in familial
hypercholesterolemia. N. Engl. J. Med. 356, 148–156.
Di Leo, E., Lancellotti, S., Penacchioni, J.Y., Cefalu, A.B., Averna,M., Pisciotta,
L., Bertolini, S., Calandra, S., Gabelli, C., and Tarugi, P. (2005). Mutations in
MTP gene in abeta- and hypobeta-lipoproteinemia. Atherosclerosis 180,
311–318.
Dougan, S.K., Rava, P., Hussain, M.M., and Blumberg, R.S. (2007). MTP
regulated by an alternate promoter is essential for NKT cell development.
J. Exp. Med. 204, 533–545.
Gordon, D.A., Jamil, H., Sharp, D., Mullaney, D., Yao, Z., Gregg, R.E., and
Wetterau, J. (1994). Secretion of apolipoprotein B-containing lipoproteins
from HeLa cells is dependent on expression of the microsomal triglyceride
transfer protein and is regulated by lipid availability. Proc. Natl. Acad. Sci.
USA 91, 7628–7632.
Cell Metabolism
Regulation of MTP by IRE1bHagan, D.L., Kienzle, B., Jamil, H., and Hariharan, N. (1994). Transcriptional
regulation of human and hamster microsomal triglyceride transfer protein
genes. Cell type-specific expression and response to metabolic regulators.
J. Biol. Chem. 269, 28737–28744.
Hirokane, H., Nakahara, M., Tachibana, S., Shimizu, M., and Sato, R. (2004).
Bile acid reduces the secretion of very low density lipoprotein by repressing
microsomal triglyceride transfer protein gene expression mediated by hepato-
cyte nuclear factor-4. J. Biol. Chem. 279, 45685–45692.
Hollien, J., and Weissman, J.S. (2006). Decay of endoplasmic reticulum-local-
ized mRNAs during the unfolded protein response. Science 313, 104–107.
Houseley, J., LaCava, J., and Tollervey, D. (2006). RNA-quality control by the
exosome. Nat. Rev. Mol. Cell Biol. 7, 529–539.
Hussain, M.M. (2000). A proposed model for the assembly of chylomicrons.
Atherosclerosis 148, 1–15.
Hussain, M.M., Kancha, R.K., Zhou, Z., Luchoomun, J., Zu, H., and Bakillah, A.
(1996). Chylomicron assembly and catabolism: role of apolipoproteins and
receptors. Biochim. Biophys. Acta 1300, 151–170.
Hussain, M.M., Iqbal, J., Anwar, K., Rava, P., and Dai, K. (2003a). Microsomal
triglyceride transfer protein: a multifunctional protein. Front. Biosci. 8, S500–
S506.
Hussain, M.M., Shi, J., and Dreizen, P. (2003b). Microsomal triglyceride
transfer protein and its role in apolipoprotein B-lipoprotein assembly. J. Lipid
Res. 44, 22–32.
Hussain, M.M., Fatma, S., Pan, X., and Iqbal, J. (2005). Intestinal lipoprotein
assembly. Curr. Opin. Lipidol. 16, 281–285.
Iqbal, J., and Hussain, M.M. (2005). Evidence for multiple complementary
pathways for efficient cholesterol absorption in mice. J. Lipid Res. 46, 1491–
1501.
Iqbal, J., Anwar, K., and Hussain, M.M. (2003). Multiple, independently
regulated pathways of cholesterol transport across the intestinal epithelial
cells. J. Biol. Chem. 278, 31610–31620.
Iwawaki, T., Hosoda, A., Okuda, T., Kamigori, Y., Nomura-Furuwatari, C.,
Kimata, Y., Tsuru, A., and Kohno, K. (2001). Translational control by the ER
transmembrane kinase/ribonuclease IRE1 under ER stress. Nat. Cell Biol. 3,
158–164.
Kang, S., Spann, N.J., Hui, T.Y., and Davis, R.A. (2003). ARP-1/COUP-TF II
determines hepatoma phenotype by acting as both a transcriptional repressor
of microsomal triglyceride transfer protein and an inducer of CYP7A1. J. Biol.
Chem. 278, 30478–30486.
Leiper, J.M., Bayliss, J.D., Pease, R.J., Brett, D.J., Scott, J., and Shoulders,
C.C. (1994). Microsomal triglyceride transfer protein, the abetalipoproteinemia
gene product, mediates the secretion of apolipoprotein B-containing lipopro-
teins from heterologous cells. J. Biol. Chem. 269, 21951–21954.
Leung, G.K., Veniant, M.M., Kim, S.K., Zlot, C.H., Raabe, M., Bjorkegren, J.,
Neese, R.A., Hellerstein, M.K., and Young, S.G. (2000). A deficiency of micro-
somal triglyceride transfer protein reduces apolipoprotein B secretion. J. Biol.
Chem. 275, 7515–7520.
Lin, M.C.M., Arbeeny, C., Bergquist, K., Kienzle, B., Gordon, D.A., and
Wetterau, J.R. (1994). Cloning and regulation of hamster microsomal triglycer-
ide transfer protein. The regulation is independent from that of other hepatic
and intestinal proteins which participate in the transport of fatty acids and
triglycerides. J. Biol. Chem. 269, 29138–29145.
Lipson, K.L., Fonseca, S.G., Ishigaki, S., Nguyen, L.X., Foss, E., Bortell, R.,
Rossini, A.A., and Urano, F. (2006). Regulation of insulin biosynthesis in
pancreatic beta cells by an endoplasmic reticulum-resident protein kinase
IRE1. Cell Metab. 4, 245–254.
Luchoomun, J., andHussain,M.M. (1999). Assembly and secretion of chylomi-
crons by differentiated Caco-2 cells. Nascent triglycerides and preformed
phospholipids are preferentially used for lipoprotein assembly. J. Biol.
Chem. 274, 19565–19572.
Meyer, S., Temme, C., and Wahle, E. (2004). Messenger RNA turnover in eu-
karyotes: pathways and enzymes. Crit. Rev. Biochem. Mol. Biol. 39, 197–216.Millar, J.S., Cromley, D.A., McCoy, M.G., Rader, D.J., and Billheimer, J.T.
(2005). Determining hepatic triglyceride production in mice: comparison of
poloxamer 407 with Triton WR-1339. J. Lipid Res. 46, 2023–2028.
Napoli, C., Martin-Padura, I., de Nigris, F., Giorgio, M., Mansueto, G., Somma,
P., Condorelli, M., Sica, G., De Rosa, G., and Pelicci, P. (2003). Deletion of the
p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular
cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc. Natl.
Acad. Sci. USA 100, 2112–2116.
Narcisi, T.M., Shoulders, C.C., Chester, S.A., Read, J., Brett, D.J., Harrison,
G.B., Grantham, T.T., Fox, M.F., Povey, S., de Bruin, T.W., et al. (1995).
Mutations of the microsomal triglyceride-transfer-protein gene in abetalipo-
proteinemia. Am. J. Hum. Genet. 57, 1298–1310.
Newbury, S.F. (2006). Control of mRNA stability in eukaryotes. Biochem. Soc.
Trans. 34, 30–34.
Niwa, M., Sidrauski, C., Kaufman, R.J., and Walter, P. (1999). A role for
presenilin-1 in nuclear accumulation of Ire1 fragments and induction of the
mammalian unfolded protein response. Cell 99, 691–702.
Raabe, M., Flynn, L.M., Zlot, C.H., Wong, J.S., Ve´niant, M.M., Hamilton, R.L.,
and Young, S.G. (1998). Knockout of the abetalipoproteinemia gene in mice:
reduced lipoprotein secretion in heterozygotes and embryonic lethality in
homozygotes. Proc. Natl. Acad. Sci. USA 95, 8686–8691.
Rava, P., and Hussain, M.M. (2007). Acquisition of triacylglycerol transfer
activity by microsomal triglyceride transfer protein during evolution. Biochem-
istry 46, 12263–12274.
Rava, P., Athar, H., Johnson, C., and Hussain, M.M. (2005). Transfer of
cholesteryl esters and phospholipids as well as net deposition by microsomal
triglyceride transfer protein. J. Lipid Res. 46, 1779–1785.
Rava, P., Ojakian, G.K., Shelness, G.S., and Hussain, M.M. (2006). Phospho-
lipid transfer activity of microsomal triacylglycerol transfer protein is sufficient
for the assembly and secretion of apolipoprotein B lipoproteins. J. Biol. Chem.
281, 11019–11027.
Schwarz, M., Davis, D.L., Vick, B.R., and Russell, D.W. (2001). Genetic analy-
sis of cholesterol accumulation in inbred mice. J. Lipid Res. 42, 1812–1819.
Sellers, J.A., Hou, L., Athar, H., Hussain, M.M., and Shelness, G.S. (2003). A
Drosophila microsomal triglyceride transfer protein homolog promotes the
assembly and secretion of human apolipoprotein B. Implications for human
and insect lipid transport and metabolism. J. Biol. Chem. 278, 20367–20373.
Tietge, U.J.F., Bakillah, A., Maugeais, C., Tsukamoto, K., Hussain, M.M., and
Rader, D.J. (1999). Hepatic overexpression of microsomal triglyceride transfer
protein (MTP) results in increased in vivo secretion of VLDL triglycerides and
apolipoprotein B. J. Lipid Res. 40, 2134–2139.
Urano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding, H.P., and
Ron, D. (2000). Coupling of stress in the ER to activation of JNK protein kinases
by transmembrane protein kinase IRE1. Science 287, 664–666.
Wang, X.Z., Harding, H.P., Zhang, Y., Jolicoeur, E.M., Kuroda, M., and Ron, D.
(1998). Cloning of mammalian Ire1 reveals diversity in the ER stress responses.
EMBO J. 17, 5708–5717.
Wetterau, J.R., Gregg, R.E., Harrity, T.W., Arbeeny, C., Cap, M., Conolly, F.,
Chu, C.-H., George, R.J., Gordon, D.A., Jamil, H., et al. (1998). An MTP
inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits.
Science 282, 751–754.
Wolfrum, C., and Stoffel, M. (2006). Coactivation of Foxa2 through Pgc-1beta
promotes liver fatty acid oxidation and triglyceride/VLDL secretion. Cell
Metab. 3, 99–110.
Yoshida, H., Matsui, T., Yamamoto, A., Okada, T., and Mori, K. (2001). XBP1
mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to
produce a highly active transcription factor. Cell 107, 881–891.
Zhang, K., Wong, H.N., Song, B., Miller, C.N., Scheuner, D., and Kaufman, R.J.
(2005). The unfolded protein response sensor IRE1alpha is required at 2
distinct steps in B cell lymphopoiesis. J. Clin. Invest. 115, 268–281.Cell Metabolism 7, 445–455, May 2008 ª2008 Elsevier Inc. 455
